Stocks
Hologic Financial Statements (HOLX) |
||||||||||
| Hologicsmart-lab.ru | % | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 01.08.2023 | 30.09.2023 | 21.11.2023 | 02.02.2024 | 02.05.2024 | 02.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 984.4 | 945.3 | 945.3 | 1 013 | 1 018 | 3 922 | |||
| Operating Income, bln rub | 1.40 | 132.5 | 132.5 | 198.2 | 210.4 | 673.6 | ||||
| EBITDA, bln rub | ? | 167.4 | 305.5 | 305.5 | 198.2 | 210.4 | 1 020 | |||
| Net profit, bln rub | ? | -40.5 | 90.6 | 90.6 | 246.5 | 169.9 | 597.6 | |||
| OCF, bln rub | ? | 332.8 | 258.7 | 258.7 | 220.0 | 0.000 | 737.4 | |||
| CAPEX, bln rub | ? | 36.5 | 52.5 | 52.5 | 38.0 | 0.000 | 143.0 | |||
| FCF, bln rub | ? | 296.3 | 206.2 | 206.2 | 182.0 | 0.000 | 594.4 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 319.7 | 311.5 | 311.5 | 340.8 | 331.9 | 1 296 | ||||
| Cost of production, bln rub | 616.9 | 445.0 | 445.0 | 445.6 | 475.5 | 1 811 | ||||
| R&D, bln rub | 72.6 | 72.9 | 72.9 | 66.8 | 74.6 | 287.2 | ||||
| Interest expenses, bln rub | 27.7 | 28.1 | 28.1 | 26.0 | 32.3 | 114.5 | ||||
| Assets, bln rub | 9 338 | 9 139 | 9 139 | 8 470 | 8 714 | 8 714 | ||||
| Net Assets, bln rub | ? | 5 182 | 5 017 | 5 017 | 4 654 | 4 844 | 4 844 | |||
| Debt, bln rub | 2 821 | 2 818 | 2 818 | 2 578 | 2 552 | 2 552 | ||||
| Cash, bln rub | 2 765 | 2 723 | 2 723 | 1 932 | 2 180 | 2 180 | ||||
| Net debt, bln rub | 56.1 | 95.7 | 95.7 | 645.9 | 371.5 | 371.5 | ||||
| Ordinary share price, rub | 81.0 | 69.4 | 69.4 | 71.5 | 78.0 | 66.6 | ||||
| Number of ordinary shares, mln | 246.9 | 245.1 | 245.1 | 238.6 | 235.9 | 235.9 | ||||
| Market cap, bln rub | 19 992 | 17 012 | 17 012 | 17 050 | 18 390 | 15 701 | ||||
| EV, bln rub | ? | 20 048 | 17 108 | 17 108 | 17 696 | 18 761 | 16 072 | |||
| Book value, bln rub | 944 | 5 017 | 847 | 515 | 4 844 | 4 844 | ||||
| EPS, rub | ? | -0.16 | 0.37 | 0.37 | 1.03 | 0.72 | 2.53 | |||
| FCF/share, rub | 1.20 | 0.84 | 0.84 | 0.76 | 0.00 | 2.52 | ||||
| BV/share, rub | 3.82 | 20.5 | 3.46 | 2.16 | 20.5 | 20.5 | ||||
| EBITDA margin, % | ? | 17.0% | 32.3% | 32.3% | 19.6% | 20.7% | 26.0% | |||
| Net margin, % | ? | -4.11% | 9.58% | 9.58% | 24.3% | 16.7% | 15.2% | |||
| FCF yield, % | ? | 4.60% | 6.61% | 6.61% | 5.04% | 3.72% | 3.79% | |||
| ROE, % | ? | 10.7% | 12.8% | 12.8% | 11.1% | 9.63% | 12.3% | |||
| ROA, % | ? | 5.92% | 7.04% | 7.04% | 6.08% | 5.35% | 6.86% | |||
| P/E | ? | 36.2 | 26.4 | 26.4 | 33.1 | 39.4 | 26.3 | |||
| P/FCF | 21.8 | 82.5 | 15.1 | 19.9 | 26.9 | 26.4 | ||||
| P/S | ? | 4.81 | 3.33 | 3.33 | 4.30 | 4.64 | 4.00 | |||
| P/BV | ? | 21.2 | 3.39 | 20.1 | 33.1 | 3.80 | 3.24 | |||
| EV/EBITDA | ? | 16.0 | 11.0 | 11.0 | 16.9 | 21.3 | 15.8 | |||
| Debt/EBITDA | 0.04 | 0.06 | 0.06 | 0.62 | 0.42 | 0.36 | ||||
| R&D/CAPEX, % | 198.9% | 138.9% | 138.9% | 175.8% | 200.8% | |||||
| CAPEX/Revenue, % | 3.71% | 5.55% | 5.55% | 3.75% | 0.00% | 3.65% | ||||
| Hologic shareholders | ||||||||||
